Učitavanje...
The safety and efficacy of vortioxetine for acute treatment of major depressive disorder: a systematic review and meta-analysis
BACKGROUND: Vortioxetine is the first mixed serotonin agonist and antagonist antidepressant approved in the US. We sought to evaluate all published and unpublished data available to determine the efficacy and harms of vortioxetine in adults with major depressive disorder. METHODS: We used a predefin...
Spremljeno u:
| Izdano u: | Syst Rev |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4351824/ https://ncbi.nlm.nih.gov/pubmed/25874839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13643-015-0001-y |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|